152 related articles for article (PubMed ID: 2823588)
1. Dose administration of gadolinium-DTPA in MR imaging of intracranial tumors.
Niendorf HP; Laniado M; Semmler W; Schörner W; Felix R
AJNR Am J Neuroradiol; 1987; 8(5):803-15. PubMed ID: 2823588
[TBL] [Abstract][Full Text] [Related]
2. Dose of contrast material in the MR imaging evaluation of central nervous system tumors.
Yuh WT; Halloran JI; Mayr NA; Fisher DJ; Nguyen HD; Simonson TM
J Magn Reson Imaging; 1994; 4(3):243-9. PubMed ID: 8061421
[No Abstract] [Full Text] [Related]
3. Brain metastases--comparison of gadodiamide injection-enhanced MR imaging at standard and high dose, contrast-enhanced CT and non-contrast-enhanced MR imaging.
Akeson P; Larsson EM; Kristoffersen DT; Jonsson E; Holtås S
Acta Radiol; 1995 May; 36(3):300-6. PubMed ID: 7742127
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity of Gd-DTPA-enhanced MR imaging of benign extraaxial tumors.
Haughton VM; Rimm AA; Czervionke LF; Breger RK; Fisher ME; Papke RA; Hendrix LE; Strother CM; Turski PA; Williams AL
Radiology; 1988 Mar; 166(3):829-33. PubMed ID: 3340779
[TBL] [Abstract][Full Text] [Related]
5. Administration of gadopentetate dimeglumine in MR imaging of intracranial tumors: dosage and field strength.
Haustein J; Laniado M; Niendorf HP; Hilbertz T; Planitzer J; Schörner W; Louton T
AJNR Am J Neuroradiol; 1992; 13(4):1199-206. PubMed ID: 1636537
[TBL] [Abstract][Full Text] [Related]
6. The application of contrast agents in the evaluation of neoplasms of the central nervous system.
Yuh WT; Fisher DJ; Nguyen HD; Tali ET; Mayr NA
Top Magn Reson Imaging; 1992 Sep; 4(4):1-6. PubMed ID: 1419031
[TBL] [Abstract][Full Text] [Related]
7. The utility of contrast media in MRI at 0.02 T. A preliminary report.
Kormano M; Niemi P; Paajanen H; Määttänen H; Katevuo K
Invest Radiol; 1988 Sep; 23 Suppl 1():S289-91. PubMed ID: 3198364
[TBL] [Abstract][Full Text] [Related]
8. Gd-DTPA administered MR imaging of intracranial mass lesions: a comparison with CT and precontrast MR.
Mihara F; Hirakata R; Hasuo K; Yasumori K; Yoshida K; Kuroiwa T; Masuda K; Fukui M
Radiat Med; 1989; 7(5):227-35. PubMed ID: 2629036
[TBL] [Abstract][Full Text] [Related]
9. Increased detection of intracranial metastases with intravenous Gd-DTPA.
Healy ME; Hesselink JR; Press GA; Middleton MS
Radiology; 1987 Dec; 165(3):619-24. PubMed ID: 3317496
[TBL] [Abstract][Full Text] [Related]
10. [Oral contrast media for the magnetic resonance tomography of the abdomen. A clinical trial of the tolerance for gadolinium-DTPA].
Kaminsky S; Laniado M; Gogoll M; Kornmesser W; Clauss W; Felix R
Rofo; 1992 Jan; 156(1):17-23. PubMed ID: 1733470
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance imaging of acoustic neuromas: the role of gadolinium-DTPA.
Stack JP; Ramsden RT; Antoun NM; Lye RH; Isherwood I; Jenkins JP
Br J Radiol; 1988 Sep; 61(729):800-5. PubMed ID: 3179642
[TBL] [Abstract][Full Text] [Related]
12. [Gadolinium DTPA in a MR study of expansive lesions of the cranial base].
Bartolozzi C; Olmastroni M; Dal Pozzo G; Petacchi D
Radiol Med; 1988 Sep; 76(3):152-7. PubMed ID: 3175068
[TBL] [Abstract][Full Text] [Related]
13. Contrast enhancement of brain tumors at different MR field strengths: comparison of 0.5 T and 2.0 T.
Chang KH; Ra DG; Han MH; Cha SH; Kim HD; Han MC
AJNR Am J Neuroradiol; 1994 Sep; 15(8):1413-9; discussion 1420-3. PubMed ID: 7985558
[TBL] [Abstract][Full Text] [Related]
14. Gadolinium-enhanced magnetization transfer contrast imaging of intracranial tumors.
Kurki TJ; Niemi PT; Lundbom N
J Magn Reson Imaging; 1992; 2(4):401-6. PubMed ID: 1633392
[TBL] [Abstract][Full Text] [Related]
15. MR imaging of the gastrointestinal tract with i.v., gadolinium and diluted barium oral contrast media compared with unenhanced MR imaging and CT.
Low RN; Francis IR
AJR Am J Roentgenol; 1997 Oct; 169(4):1051-9. PubMed ID: 9308464
[TBL] [Abstract][Full Text] [Related]
16. Dosing of Gd-DTPA in MR imaging of intracranial tumors.
Schubeus P; Schörner W; Haustein J
Magn Reson Med; 1991 Dec; 22(2):249-54; discussion 265-7. PubMed ID: 1812354
[No Abstract] [Full Text] [Related]
17. Dynamic MRI with slow injection of contrast material for the diagnosis of pituitary adenoma.
Hayashi S; Ito K; Shimada M; Tsubuku M; Kaneko I; Kogure T; Kusama K; Nanba T; Senoh A; Tsuchida S
Radiat Med; 1995; 13(4):167-70. PubMed ID: 8539442
[TBL] [Abstract][Full Text] [Related]
18. Gd-enhanced MR imaging of brain metastases: contrast as a function of dose and lesion size.
Van Dijk P; Sijens PE; Schmitz PI; Oudkerk M
Magn Reson Imaging; 1997; 15(5):535-41. PubMed ID: 9253997
[TBL] [Abstract][Full Text] [Related]
19. MRI evaluation of "solitary" brain metastases with triple-dose gadoteridol: comparison with contrast-enhanced CT and conventional-dose gadopentetate dimeglumine MRI studies in the same patients.
Kuhn MJ; Hammer GM; Swenson LC; Youssef HT; Gleason TJ
Comput Med Imaging Graph; 1994; 18(5):391-9. PubMed ID: 7954317
[TBL] [Abstract][Full Text] [Related]
20. MR imaging of pituitary region lesions with gadodiamide injection.
Hald JK; Skalpe IO; Bakke SJ; Nakstad PH
Acta Radiol; 1994 Jan; 35(1):65-9. PubMed ID: 8305277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
